source
- Trump touts completion of first round of White House drug pricing deals with RegeneronPresident Trump announced that a pricing agreement with Regeneron marks the final deal of an initial slate of 17 sought by the administration. Under the private arrangement, Regeneron will lower Me…
- Trump administration allocates $50 million to psychedelic research and moves to downgrade medical marijuanaPresident Trump signed an executive order that earmarks $50 million for research into psychedelics as potential mental‑health treatments and directs the FDA to accelerate their review process. The…